Cargando…

Exploring the variability of sarcopenia prevalence in a research population using different disease definitions

BACKGROUND: Sarcopenia is the progressive loss of muscle mass and function with age. A number of different sarcopenia definitions have been proposed and utilised in research. This study aimed to investigate how the prevalence of sarcopenia in a research cohort of older adults is influenced by the us...

Descripción completa

Detalles Bibliográficos
Autores principales: Cegielski, Jessica, Bass, Joseph J., Willott, Ruth, Gordon, Adam L., Wilkinson, Daniel J., Smith, Ken, Atherton, Philip J., Phillips, Bethan E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520157/
https://www.ncbi.nlm.nih.gov/pubmed/37466861
http://dx.doi.org/10.1007/s40520-023-02496-7
_version_ 1785109852467494912
author Cegielski, Jessica
Bass, Joseph J.
Willott, Ruth
Gordon, Adam L.
Wilkinson, Daniel J.
Smith, Ken
Atherton, Philip J.
Phillips, Bethan E.
author_facet Cegielski, Jessica
Bass, Joseph J.
Willott, Ruth
Gordon, Adam L.
Wilkinson, Daniel J.
Smith, Ken
Atherton, Philip J.
Phillips, Bethan E.
author_sort Cegielski, Jessica
collection PubMed
description BACKGROUND: Sarcopenia is the progressive loss of muscle mass and function with age. A number of different sarcopenia definitions have been proposed and utilised in research. This study aimed to investigate how the prevalence of sarcopenia in a research cohort of older adults is influenced by the use of independent aspects of these different definitions. METHODS: Data from 255 research participants were compiled. Defining criteria by the European Working Group on Sarcopenia in Older People, the International Working Group on Sarcopenia (IWGS), and the Foundation for the National Institutes of Health were applied. RESULTS: Prevalence of sarcopenia using muscle mass ranged from 4 to 22%. Gait speed and handgrip strength criteria identified 4–34% and 4–16% of participants as sarcopenic, respectively. CONCLUSION: Prevalence of sarcopenia differs substantially depending on the criteria used. Work is required to address the impact of this for sarcopenia research to be usefully translated to inform on clinical practice.
format Online
Article
Text
id pubmed-10520157
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-105201572023-09-27 Exploring the variability of sarcopenia prevalence in a research population using different disease definitions Cegielski, Jessica Bass, Joseph J. Willott, Ruth Gordon, Adam L. Wilkinson, Daniel J. Smith, Ken Atherton, Philip J. Phillips, Bethan E. Aging Clin Exp Res Short Communication BACKGROUND: Sarcopenia is the progressive loss of muscle mass and function with age. A number of different sarcopenia definitions have been proposed and utilised in research. This study aimed to investigate how the prevalence of sarcopenia in a research cohort of older adults is influenced by the use of independent aspects of these different definitions. METHODS: Data from 255 research participants were compiled. Defining criteria by the European Working Group on Sarcopenia in Older People, the International Working Group on Sarcopenia (IWGS), and the Foundation for the National Institutes of Health were applied. RESULTS: Prevalence of sarcopenia using muscle mass ranged from 4 to 22%. Gait speed and handgrip strength criteria identified 4–34% and 4–16% of participants as sarcopenic, respectively. CONCLUSION: Prevalence of sarcopenia differs substantially depending on the criteria used. Work is required to address the impact of this for sarcopenia research to be usefully translated to inform on clinical practice. Springer International Publishing 2023-07-19 2023 /pmc/articles/PMC10520157/ /pubmed/37466861 http://dx.doi.org/10.1007/s40520-023-02496-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Short Communication
Cegielski, Jessica
Bass, Joseph J.
Willott, Ruth
Gordon, Adam L.
Wilkinson, Daniel J.
Smith, Ken
Atherton, Philip J.
Phillips, Bethan E.
Exploring the variability of sarcopenia prevalence in a research population using different disease definitions
title Exploring the variability of sarcopenia prevalence in a research population using different disease definitions
title_full Exploring the variability of sarcopenia prevalence in a research population using different disease definitions
title_fullStr Exploring the variability of sarcopenia prevalence in a research population using different disease definitions
title_full_unstemmed Exploring the variability of sarcopenia prevalence in a research population using different disease definitions
title_short Exploring the variability of sarcopenia prevalence in a research population using different disease definitions
title_sort exploring the variability of sarcopenia prevalence in a research population using different disease definitions
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520157/
https://www.ncbi.nlm.nih.gov/pubmed/37466861
http://dx.doi.org/10.1007/s40520-023-02496-7
work_keys_str_mv AT cegielskijessica exploringthevariabilityofsarcopeniaprevalenceinaresearchpopulationusingdifferentdiseasedefinitions
AT bassjosephj exploringthevariabilityofsarcopeniaprevalenceinaresearchpopulationusingdifferentdiseasedefinitions
AT willottruth exploringthevariabilityofsarcopeniaprevalenceinaresearchpopulationusingdifferentdiseasedefinitions
AT gordonadaml exploringthevariabilityofsarcopeniaprevalenceinaresearchpopulationusingdifferentdiseasedefinitions
AT wilkinsondanielj exploringthevariabilityofsarcopeniaprevalenceinaresearchpopulationusingdifferentdiseasedefinitions
AT smithken exploringthevariabilityofsarcopeniaprevalenceinaresearchpopulationusingdifferentdiseasedefinitions
AT athertonphilipj exploringthevariabilityofsarcopeniaprevalenceinaresearchpopulationusingdifferentdiseasedefinitions
AT phillipsbethane exploringthevariabilityofsarcopeniaprevalenceinaresearchpopulationusingdifferentdiseasedefinitions